NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
NHS National Proprietary Pharmaceuticals – Low Molecular Weight Heparins and Fondaparinux Products – CM/PHR/25/5732 Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
Buyer
NHS England
Value
£321,349,256
Published
18 Dec 2025
Closes
22 Oct 2025
Procurement details
Source
Find a Tender
Region
Lambeth
Procurement method
Open
Category
Goods
Contract starts
1 Mar 2026
Contract ends
29 Feb 2028
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
£176,000,000
Delivery: UKC · United Kingdom, UKD · United Kingdom, UKF · United Kingdom, UKG · United Kingdom, UKH · United Kingdom, UKJ · United Kingdom
Documents
Unlock document linkUntitled document
Not provided
Bidding documents · Excel spreadsheet
Untitled document
Not provided
Bidding documents · Word document
Untitled document
Not provided
Bidding documents · XML
Untitled document
Not provided
Bidding documents · Word document
Untitled document
Not provided
Bidding documents · Word document
Untitled document
Not provided
Bidding documents · Excel spreadsheet
Untitled document
Not provided
Bidding documents · Word document
Untitled document
Not provided
Bidding documents · Word document
Untitled document
Not provided
Bidding documents · Word document
Untitled document
Not provided
Bidding documents · Excel spreadsheet
Untitled document
Not provided
Bidding documents · Word document
Untitled document
Not provided
Bidding documents · Excel spreadsheet
Contains public sector information licensed under the Open Government Licence v3.0.